Medical information contained on this website is for educational purposes only. Prospective patients are encouraged to consult with their personal physician prior to seeking stem cell therapy or treatments.
Regenerative medicine has been called the next evolution of medical treatments by the U.S. Department of Health and Human Services. With its potential to heal, this new field of science is expected to revolutionize health care.
All stem cell research carried out by BioXcellerator researchers and scientists follows strict scientific and ethical guidelines as directed by the National Institutes of Health.
As a member of the International Society of Stem Cell Research (ISSCR), BioXcellerator also works in accordance with ISSCR guidelines and the International Society for Cellular Therapy.
Our stem cell therapy procedures are in compliance with FDA regulations CFR21 Part 1271 (1271.15.b). Stem cell transplants or bone marrow transplants are regular clinical practice in the United States and many other countries and have been for more than 25 years. Stem cell transplants or bone marrow transplants are being used to treat patients with hematological disorders such as sickle cell anemia, thalassemia, leukemia, and lymphomas among others.
BioXcellerator and Bioscience Americas also follows the ethical guidelines in accordance with the World Medical Association’s WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects — “In the treatment of a patient, where proven interventions do not exist or have been ineffective, the physician may use an unproven intervention if in the physician’s judgment it offers hope of saving life, re-establishing health or alleviating suffering.”
Any and all opinions and/or statements offered on this website are for information and education purpose only. Bioscience Americas, BioXcellerator, or and its affiliate centers are offering certain investigational treatments using Stromal Vascular Fraction (SVF) which uses patients own stem cells which are called autologous stem cell transplant. The centers only provide surgical procedures and centers are not involved in the use or manufacture of any investigational drugs.
This website does not claim that any applications using autologous stem cells offer a cure for any medical condition. This website does not offer any medical advice. It is critically important for any patient to do his or her own research to reach an informed decision. It is a completely voluntary decision by any and all patients to participate in some of our patient funded clinical studies at various locations around the world. The result varies from patient to patient. The testimonials do not constitute typical results nor do we claim that they do.
Moreover, each country has its own country-specific stem cell regulations depending on its need. Bioscience Americas and BioXcellerator follow guidelines set up by the host government. Furthermore, BioXcellerator is working with governments worldwide and developing stem cell research and transplant programs for millions of people globally suffering from genetic and hematological diseases.